πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 30 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9623085

Chimeric natriuretic peptide compositions and methods of preparation

Capricor Therapeutics, Inc. Β· Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9616107

Therapy for kidney disease and/or heart failure

Capricor Therapeutics, Inc. Β· Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9314507

Methods of treatment of heart failure with natriuretic peptides

Capricor Therapeutics, Inc. Β· Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 6399627

Inhibitors of factor Xa

COR Therapeutics, Inc. Β· Granted Tue Jun 04 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6376515

Benzamides and related inhibitors of factor Xa

COR Therapeutics, Inc. Β· Granted Tue Apr 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6369080

Selective factor Xa inhibitors

COR Therapeutics, Inc. Β· Granted Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6369063

Selective factor Xa inhibitors

COR Therapeutics, Inc. Β· Granted Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6333321

Selective factor Xa inhibitors

COR Therapeutics, Inc. Β· Granted Tue Dec 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6297026

Nucleic acids encoding the C140 receptor

COR Therapeutics, Inc. Β· Granted Tue Oct 02 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6291469

Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation

COR Therapeutics, Inc. Β· Granted Tue Sep 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6262047

Selective factor Xa inhibitors

COR Therapeutics, Inc. Β· Granted Tue Jul 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6245743

Inhibitors of factor Xa

COR Therapeutics, Inc. Β· Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6228854

Selective factor Xa inhibitors

COR Therapeutics, Inc. Β· Granted Tue May 08 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6218382

Selective factor Xa inhibitors

COR Therapeutics, Inc. Β· Granted Tue Apr 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6210913

Modulation of integrin-mediated signal transduction

COR Therapeutics, Inc. Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6211154

Ketoheterocyclic inhibitors of factor Xa

COR Therapeutics, Inc. Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6211183

Selective factor Xa inhibitors

COR Therapeutics, Inc. Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6204268

Selective factor Xa inhibitors

COR Therapeutics, Inc. Β· Granted Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6197748

Ketoheterocyclic inhibitors of factor Xa

COR Therapeutics, Inc. Β· Granted Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6194557

Nucleic acid molecules encoding Bap-1 proteins

COR Therapeutics, Inc. Β· Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6133256

Selective factor Xa inhibitors

COR Therapeutics, Inc. Β· Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6117836

Glycosylation-mediated inhibition of factor X

COR Therapeutics, Inc. Β· Granted Tue Sep 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6083688

Platelet glycoprotein V gene and uses

COR Therapeutics, Inc. Β· Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6069130

Ketoheterocyclic inhibitors of factor Xa

COR Therapeutics, Inc. Β· Granted Tue May 30 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired